Should mild COPD be treated? Evidence for early pharmacological intervention. (Q38161458)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

Should mild COPD be treated? Evidence for early pharmacological intervention (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Katherine A Webb

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

J Alberto Neder

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Denis E O'Donnell

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 December 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

1991-2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

29 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Global burden of COPD: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Longitudinal change of prebronchodilator spirometric obstruction and health outcomes: results from the SAPALDIA cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

COPD prevalence in a random population survey: a matter of definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Early detection and impaired quality of life in COPD GOLD stage 0: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Do GOLD stages of COPD severity really correspond to differences in health status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Health status measurement in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Development and first validation of the COPD Assessment Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Lower limb activity and its determinants in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Sex differences in exertional dyspnea in patients with mild COPD: Physiological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Prevalence of airflow obstruction in smokers and never-smokers in Switzerland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Lung hyperinflation and its reversibility in patients with airway obstruction of varying severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Changes in Forced Expiratory Volume in 1 Second over Time in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Site and Nature of Airway Obstruction in Chronic Obstructive Lung Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

The nature of small-airway obstruction in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Small-airway obstruction and emphysema in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Emphysema — A Disease of Small Airways or Lung Parenchyma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Contributions of Loss of Lung Recoil and of Enhanced Airways Collapsibility to the Airflow Obstruction of Chronic Bronchitis and Emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Forty years of closing volume

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Noninvasive assessment of airway alterations in smokers: the small airways revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Clinical applications of forced oscillation to assess peripheral airway function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Ventilation-perfusion inequality in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Characterization of pulmonary vascular remodelling in smokers and patients with mild COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Physical inactivity in patients with COPD, a controlled multi-center pilot-study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Early changes of cardiac structure and function in COPD patients with mild hypoxemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Percent emphysema, airflow obstruction, and impaired left ventricular filling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Percent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle Studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Sub-clinical left and right ventricular dysfunction in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Endothelial microparticles in mild chronic obstructive pulmonary disease and emphysema. The Multi-Ethnic Study of Atherosclerosis Chronic Obstructive Pulmonary Disease study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Airflow limitation in smokers is associated with subclinical atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Co-morbidity in mild-to-moderate COPD: comparison to normal and restrictive lung function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Current clinical guideline definitions of airflow obstruction and COPD overdiagnosis in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Spirometric criteria for airway obstruction: Use percentage of FEV1/FVC ratio below the fifth percentile, not < 70%.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Pulmonary function, smoking cessation and 30 year mortality in middle aged Finnish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Comprehensive pulmonary rehabilitation according to severity of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

A 4-year trial of tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Bronchodilator efficacy of tiotropium in patients with mild to moderate COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Short- and long-term efficacy of fluticasone propionate in subjects with early signs and symptoms of chronic obstructive pulmonary disease. Results of the DIMCA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Possible protection by inhaled budesonide against ischaemic cardiac events in mild COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Acute exacerbation of chronic obstructive pulmonary disease in primary care setting in Spain: the EPOCAP study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Budesonide added to formoterol contributes to improved exercise tolerance in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

High-dose N-acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Recommendations for epidemiological studies on COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Prediction of the Clinical Course of Chronic Obstructive Pulmonary Disease, Using the New GOLD Classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0145-9

COPD exacerbations: definitions and classifications.

21 January 2018

1 reference

12 December 2020

Effects of salmeterol on arterial blood gases in patients with stable chronic obstructive pulmonary disease. Comparison with albuterol and ipratropium

1 reference

12 December 2020

Effect of adjunct fluticasone propionate on airway physiology during rest and exercise in COPD

1 reference

12 December 2020

Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD

1 reference

12 December 2020

Does the respiratory system limit exercise in mild chronic obstructive pulmonary disease?

1 reference

12 December 2020

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease

1 reference

12 December 2020

Walking exercise response to bronchodilation in mild COPD: a randomized trial

1 reference

12 December 2020

Assessment of Small-Airways Disease Using Alveolar Nitric Oxide and Impulse Oscillometry in Asthma and COPD

1 reference

12 December 2020

Respiratory viral infections in adults with and without chronic obstructive pulmonary disease

1 reference

12 December 2020

Mechanism of expiratory airflow limitation in chronic obstructive pulmonary disease associated with 1 -antitrypsin deficiency

1 reference

12 December 2020

Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease

1 reference

12 December 2020

Lung Function and Risk of Myocardial Infarction and Sudden Cardiac Death

1 reference

12 December 2020

Components of the COPD Assessment Test (CAT) associated with a diagnosis of COPD in a random population sample

1 reference

12 December 2020

Ventilation-perfusion imbalance and chronic obstructive pulmonary disease staging severity

1 reference

12 December 2020

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update

1 reference

12 December 2020

Endothelial dysfunction in pulmonary arteries of patients with mild COPD

1 reference

12 December 2020

COPD as a multicomponent disease: Inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care

1 reference

12 December 2020

Physiologic diagnosis of subclinical emphysema

1 reference

12 December 2020

Sub-clinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary disease

1 reference

12 December 2020

Are patient characteristics helpful in recognizing mild COPD (GOLD I) in daily practice?

1 reference

12 December 2020

Early detection of COPD in a high-risk population using spirometric screening

1 reference

12 December 2020

Mechanisms of dyspnea during cycle exercise in symptomatic patients with GOLD stage I chronic obstructive pulmonary disease

1 reference

12 December 2020

Exercise rehabilitation and chronic obstructive pulmonary disease stage

1 reference

12 December 2020

Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease

1 reference

12 December 2020

Lung structure and gas exchange in mild chronic obstructive pulmonary disease

1 reference

12 December 2020

Pooled clinical trial analysis of tiotropium safety

1 reference

12 December 2020

Chronic obstructive pulmonary disease surveillance--United States, 1971-2000

1 reference

12 December 2020

Tiotropium in COPD patients not previously receiving maintenance respiratory medications

1 reference

12 December 2020

Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2008 update - highlights for primary care

1 reference

12 December 2020

10.1007/S40265-013-0145-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

29 February 2020

1031606805

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24214364%20AND%20SRC:MED&resulttype=core&format=json